Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia

Takuma Fujii, Nobuo Masumoto, Miyuki Saito, Nobumaru Hirao, Shinichi Niimi, Makio Mukai, Akiko Ono, Shigenori Hayashi, Kaneyuki Kubushiro, Eiichi Sakai, Katsumi Tsukazaki, Shiro Nozawa

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Integration of the human papillomavirus (HPV) genome is thought to be one of the causes of cancer progression. However, there is controversy concerning the physical status of HPV 16 in premalignant cervical lesions, and there have been no reports on the concordance between detection of the integrated form of HPV16 by real-time PCR and by in situ hybridization. We investigated specimens of cervical intraepithelial neoplasia (CIN) and invasive carcinomas for the physical status of HPV 16 by real-time PCR and in situ hybridization. The presence of the integrated form was detected by both real-time PCR and in situ hybridization in zero of four cases of CIN1, three of six cases of CIN2, nine of 27 cases of CIN3, and two of six cases of invasive carcinomas. Integrated HPV 16 was present in some premalignant lesions but was not always present in carcinomas. The concordance rate between the two methods for the detection of the presence of the integrated form was 37 of 43 (86%) cases. Real-time PCR and in situ hybridization were found to be complementary and convenient techniques for determining the physical status of the HPV genome. We conclude that a combination of both methods is a more reliable means of assessing the physical status of the HPV genome in cervical neoplasia.

Original languageEnglish
Pages (from-to)103-108
Number of pages6
JournalDiagnostic Molecular Pathology
Volume14
Issue number2
DOIs
Publication statusPublished - 01-06-2005
Externally publishedYes

Fingerprint

Human papillomavirus 16
In Situ Hybridization
Real-Time Polymerase Chain Reaction
Human Genome
Carcinoma
Neoplasms
Cervical Intraepithelial Neoplasia

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Fujii, Takuma ; Masumoto, Nobuo ; Saito, Miyuki ; Hirao, Nobumaru ; Niimi, Shinichi ; Mukai, Makio ; Ono, Akiko ; Hayashi, Shigenori ; Kubushiro, Kaneyuki ; Sakai, Eiichi ; Tsukazaki, Katsumi ; Nozawa, Shiro. / Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. In: Diagnostic Molecular Pathology. 2005 ; Vol. 14, No. 2. pp. 103-108.
@article{e880b884d11d4f2cac880a03cebb13dd,
title = "Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia",
abstract = "Integration of the human papillomavirus (HPV) genome is thought to be one of the causes of cancer progression. However, there is controversy concerning the physical status of HPV 16 in premalignant cervical lesions, and there have been no reports on the concordance between detection of the integrated form of HPV16 by real-time PCR and by in situ hybridization. We investigated specimens of cervical intraepithelial neoplasia (CIN) and invasive carcinomas for the physical status of HPV 16 by real-time PCR and in situ hybridization. The presence of the integrated form was detected by both real-time PCR and in situ hybridization in zero of four cases of CIN1, three of six cases of CIN2, nine of 27 cases of CIN3, and two of six cases of invasive carcinomas. Integrated HPV 16 was present in some premalignant lesions but was not always present in carcinomas. The concordance rate between the two methods for the detection of the presence of the integrated form was 37 of 43 (86{\%}) cases. Real-time PCR and in situ hybridization were found to be complementary and convenient techniques for determining the physical status of the HPV genome. We conclude that a combination of both methods is a more reliable means of assessing the physical status of the HPV genome in cervical neoplasia.",
author = "Takuma Fujii and Nobuo Masumoto and Miyuki Saito and Nobumaru Hirao and Shinichi Niimi and Makio Mukai and Akiko Ono and Shigenori Hayashi and Kaneyuki Kubushiro and Eiichi Sakai and Katsumi Tsukazaki and Shiro Nozawa",
year = "2005",
month = "6",
day = "1",
doi = "10.1097/01.pas.0000162755.84026.9f",
language = "English",
volume = "14",
pages = "103--108",
journal = "Diagnostic Molecular Pathology",
issn = "1052-9551",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. / Fujii, Takuma; Masumoto, Nobuo; Saito, Miyuki; Hirao, Nobumaru; Niimi, Shinichi; Mukai, Makio; Ono, Akiko; Hayashi, Shigenori; Kubushiro, Kaneyuki; Sakai, Eiichi; Tsukazaki, Katsumi; Nozawa, Shiro.

In: Diagnostic Molecular Pathology, Vol. 14, No. 2, 01.06.2005, p. 103-108.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia

AU - Fujii, Takuma

AU - Masumoto, Nobuo

AU - Saito, Miyuki

AU - Hirao, Nobumaru

AU - Niimi, Shinichi

AU - Mukai, Makio

AU - Ono, Akiko

AU - Hayashi, Shigenori

AU - Kubushiro, Kaneyuki

AU - Sakai, Eiichi

AU - Tsukazaki, Katsumi

AU - Nozawa, Shiro

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Integration of the human papillomavirus (HPV) genome is thought to be one of the causes of cancer progression. However, there is controversy concerning the physical status of HPV 16 in premalignant cervical lesions, and there have been no reports on the concordance between detection of the integrated form of HPV16 by real-time PCR and by in situ hybridization. We investigated specimens of cervical intraepithelial neoplasia (CIN) and invasive carcinomas for the physical status of HPV 16 by real-time PCR and in situ hybridization. The presence of the integrated form was detected by both real-time PCR and in situ hybridization in zero of four cases of CIN1, three of six cases of CIN2, nine of 27 cases of CIN3, and two of six cases of invasive carcinomas. Integrated HPV 16 was present in some premalignant lesions but was not always present in carcinomas. The concordance rate between the two methods for the detection of the presence of the integrated form was 37 of 43 (86%) cases. Real-time PCR and in situ hybridization were found to be complementary and convenient techniques for determining the physical status of the HPV genome. We conclude that a combination of both methods is a more reliable means of assessing the physical status of the HPV genome in cervical neoplasia.

AB - Integration of the human papillomavirus (HPV) genome is thought to be one of the causes of cancer progression. However, there is controversy concerning the physical status of HPV 16 in premalignant cervical lesions, and there have been no reports on the concordance between detection of the integrated form of HPV16 by real-time PCR and by in situ hybridization. We investigated specimens of cervical intraepithelial neoplasia (CIN) and invasive carcinomas for the physical status of HPV 16 by real-time PCR and in situ hybridization. The presence of the integrated form was detected by both real-time PCR and in situ hybridization in zero of four cases of CIN1, three of six cases of CIN2, nine of 27 cases of CIN3, and two of six cases of invasive carcinomas. Integrated HPV 16 was present in some premalignant lesions but was not always present in carcinomas. The concordance rate between the two methods for the detection of the presence of the integrated form was 37 of 43 (86%) cases. Real-time PCR and in situ hybridization were found to be complementary and convenient techniques for determining the physical status of the HPV genome. We conclude that a combination of both methods is a more reliable means of assessing the physical status of the HPV genome in cervical neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=21144433349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21144433349&partnerID=8YFLogxK

U2 - 10.1097/01.pas.0000162755.84026.9f

DO - 10.1097/01.pas.0000162755.84026.9f

M3 - Article

VL - 14

SP - 103

EP - 108

JO - Diagnostic Molecular Pathology

JF - Diagnostic Molecular Pathology

SN - 1052-9551

IS - 2

ER -